Home › Infezioni virali › Distretto di Columbia › Washington
Studi clinici su Infezioni virali a Washington, DC
12 studi su Infezioni virali cercano partecipanti presso sedi a Washington e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
In reclutamentoFase 3
- Research Site, Washington D.C.
Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
In reclutamentoStudio osservazionale
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
In reclutamentoStudio osservazionale
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection
In reclutamentoFase 1Volontari sani benvenuti
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
In reclutamentoFase 3
- Georgetown University Medical Center, Washington D.C.
- Emerson Clinical Research Institute, Washington D.C.
- Jadestone Clinical Research, Silver Spring · a 7 mi di distanza
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
In reclutamentoFase 3
- Georgetown University Medical Center, Washington D.C.
- Jadestone Clinical Research, Silver Spring · a 7 mi di distanza
A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health
In reclutamentoFase 1Volontari sani benvenuti
- George Washington University, Washington D.C.
Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults
In reclutamentoFase 1Volontari sani benvenuti
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Viral Infections in Healthy and Immunocompromised Hosts
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Genetic Studies of Chronic Active Epstein-Barr Disease
In reclutamentoStudio osservazionale
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
In reclutamentoFase 1
- Children's National Hospital, Washington D.C.
- National Institutes of Health (NIH), Bethesda · a 7 mi di distanza
Studi su Infezioni virali in altre città
- Boston, MA6 studi
- Houston, TX6 studi
- Baltimore, MD5 studi
- Hialeah, FL5 studi
- Columbus, OH4 studi
- Cincinnati, OH4 studi
- Atlanta, GA4 studi
- Dallas, TX4 studi
- New York City, NY3 studi
- St. Louis, MO3 studi
- Los Angeles, CA3 studi
- San Francisco, CA3 studi
Altri studi a Washington
- Cancro (tutti i tipi)58 studi
- Cancro del polmone non a piccole cellule55 studi
- Cancro al seno46 studi
- Cancro metastatico43 studi
- Cancro ai polmoni41 studi
- Cancro alla prostata38 studi
- Obesità33 studi
- Cancro colorettale29 studi
- Malattie cardiovascolari28 studi
- Cancro della vescica26 studi
- Leucemia mieloide acuta24 studi
- Linfoma23 studi
Fonte: ClinicalTrials.gov, dati recuperati il 7 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.